Product Description
Mechanisms of Action: NNRT Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Pfizer
Company Location: Eastern America
Company CEO: Albert Bourla
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: HIV Infections
Phase 1: HIV Infections|Tuberculosis|Cross Infection|Healthy Volunteers
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
ACTRN12619000711112p |
HER2E-PAM, PAMILIA Study | N/A |
Not yet recruiting |
Intestinal Diseases|Enterocolitis |
2023-03-01 |
|||
NCT01603485 |
A5271050 | P1 |
Completed |
Healthy Volunteers |
2012-08-01 |
2019-03-19 |
Treatments |
|
NCT01230385 |
A5271049 | P1 |
Completed |
Healthy Volunteers |
2011-05-01 |
2019-03-19 |
Treatments |
|
NCT01220232 |
A5271048 | P1 |
Completed |
Healthy Volunteers |
2011-01-01 |
2019-03-19 |
Treatments |
|
NCT00925535 |
UK-453,061 | P1 |
Completed |
Cross Infection|Tuberculosis|HIV Infections |
2010-08-01 |
2019-03-18 |
Treatments |
|
NCT01099748 |
A5271031 | P1 |
Completed |
Healthy Volunteers |
2010-06-01 |
2019-03-19 |
Treatments |
|
NCT00936871 |
A5271032 | P1 |
Completed |
HIV Infections |
2010-03-01 |
2024-11-27 |
Primary Endpoints|Treatments |
|
NCT01050751 |
A5271039 | P1 |
Completed |
Healthy Volunteers |
2010-03-01 |
2019-03-19 |
Treatments |
|
NCT00784420 |
A5271019 | P1 |
Completed |
Healthy Volunteers |
2008-11-01 |
2019-03-18 |
Treatments |
|
2008-006049-26 |
2008-006049-26 | P2 |
Terminated |
HIV Infections |
2013-07-15 |
2022-03-12 |
Treatments |
|
2010-020860-39 |
2010-020860-39 | P2 |
Terminated |
HIV Infections |
2013-04-30 |
2022-03-13 |
Treatments |
|
NCT01254656 |
A5271037 | P2 |
Terminated |
HIV Infections |
2013-04-01 |
2019-03-19 |
Treatments |
|
NCT00823979 |
A5271022 | P2 |
Terminated |
HIV Infections |
2012-10-18 |
2019-03-22 |
Treatments |
|
2007-004392-19 |
2007-004392-19 | P2 |
Terminated |
HIV Infections |
2012-10-18 |
2022-03-12 |
Treatments |
|
2007-004379-20 |
2007-004379-20 | P2 |
Completed |
HIV Infections |
2011-10-14 |
2022-03-12 |
Treatments |
|
NCT00824421 |
A5271015 | P2 |
Completed |
HIV Infections |
2011-10-01 |
2019-03-18 |
Treatments |
|
2005-004120-39 |
2005-004120-39 | P2 |
Completed |
HIV Infections |
2007-02-19 |
2022-03-12 |
Treatments |
|
NCT00348673 |
A5271010 | P2 |
Completed |
HIV Infections |
2007-02-01 |
2019-03-21 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|